Suprefort is a pancreas-targeting bioregulator peptide that supports both exocrine enzyme secretion and endocrine islet-cell function. It helps maintain the pancreas' dual role in digestion and blood-sugar regulation through epigenetic peptide signalling.
Suprefort is a precision-engineered bioregulator peptide that selectively targets pancreatic tissue through epigenetic signalling pathways. Developed from decades of Khavinson peptide research, each capsule contains ultra-short amino acid sequences (2-4 residues) that penetrate cell membranes to interact directly with tissue-specific DNA. By restoring natural gene expression patterns within pancreatic tissue cells, Suprefort helps normalise pancreatic enzyme secretion and islet-cell function—functions that progressively decline with age, stress, and environmental exposure. The peptide does not introduce foreign substances; instead, it reactivates the body's own molecular programmes for digestive tissue maintenance, making it a fundamentally different approach from conventional supplementation.